The association between knowledge of HPV and feelings of stigma, shame and anxiety
- PMID: 17098767
- PMCID: PMC2598611
- DOI: 10.1136/sti.2006.023333
The association between knowledge of HPV and feelings of stigma, shame and anxiety
Abstract
Objectives: To test the hypotheses that (1) women who know that human papillomavirus (HPV) is sexually transmitted will expect to experience higher levels of stigma, shame and anxiety if they test positive for the virus than women who are not aware of the mode of transmission and (2) women who are aware of the high prevalence of HPV infection will expect to experience lower levels of stigma, shame and anxiety than women who underestimate its prevalence.
Methods: A web-based survey in which information about HPV was manipulated to generate a 2 x 2 design (awareness that HPV is sexually transmitted v no awareness; awareness of the high prevalence of HPV v no awareness). Participants (n = 811) were female students. They were asked to imagine that they had tested positive for HPV. Outcome measures were expected stigma, shame and anxiety.
Results: Great differences were observed in emotional reactions to imagining testing HPV positive between the four groups based on knowledge of HPV. Knowledge of the prevalence was associated with lower levels of stigma, shame and anxiety. Knowledge that HPV is sexually transmitted was associated with higher levels of stigma and shame, but not anxiety. Women who knew that HPV is sexually transmitted but not that it is highly prevalent had the highest scores for stigma and shame.
Conclusions: Raising public awareness of the sexually transmitted nature of HPV has the potential to increase women's feelings of stigma and shame if they test positive for the virus. However, our findings suggest that ensuring women's awareness of HPV being common may reduce these feelings and also reduce anxiety, perhaps by "normalising" the infection.
Conflict of interest statement
Competing interests: None declared.
References
-
- Merck European Commission approves Gardasil®, Merck's cervical cancer vaccine 2006. http://www.merck.com/newsroom/press_releases/product/2006_0922a.html (accessed 24 Oct 2006)
-
- CDC CDC's advisory committee recommends human papillomavirus vaccination. 2006. http://www.cdc.gov/od/oc/media/pressrel/r060629.htm (accessed 24 Oct 2006) - PubMed